IMCV ETF Analysis: Morningstar Mid-Cap Value | NASDAQ

US Small & Mid Cap Equity | NASDAQ, USA | Market Cap: 1.284m USD | 12M Return: 26.4% | US4642884062 | Charts, Fundamentals & Technical Analysis

Mid-Cap Equities, Value Stocks, Domestic Investments
Total Rating 74
Safety 63
Buy Signal 0.30
US Small & Mid Cap Equity
Category Rotation: -1.5
TER: 0.06%
AUM: 1.28B
Avg Turnover: 4.96M
Risk 3d forecast
Volatility13.6%
VaR 5th Pctl2.42%
VaR vs Median-1.35%
Reward TTM
Sharpe Ratio1.74
Rel. Str. IBD72.3
Rel. Str. Peer Group93.6 pctl
Character TTM
Beta0.528
Beta Downside0.575
Hurst Exponent0.514
Choppyness56.4%
Drawdowns 3y
Max DD18.63%
CAGR/Max DD1.08
CAGR/Mean DD7.92

Warnings

No concerns identified

Tailwinds

No distinct edge detected

Seasonality 11.9 years of data, until 10/2026

Jan +0.3% 0
Feb +1.0% 14
Mar -1.3% 4
Apr +0.4% 4
May -0.1% 0
Jun -0.3% 4
Jul +1.4% 28
Aug -0.4% 14
Sep -2.3% 28
Oct -1.3% 14
Nov +2.5% 64
Dec -0.3% 9

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.

Description: IMCV Morningstar Mid-Cap Value

iShares Morningstar Mid-Cap Value ETF (IMCV) invests primarily in U.S. mid-capitalization stocks identified as having value characteristics under Morningstar’s index methodology. It generally holds at least 80% of its assets in index securities or substantially similar investments.

As an ETF, IMCV provides exposure to a portfolio of companies rather than operating a single business. Its holdings may span multiple sectors, with sector exposure reflecting the underlying index.

Headlines to Watch Out For
  • Mid-cap earnings and valuations drive underlying portfolio returns
  • Interest-rate shifts influence value-stock performance versus growth
  • Index rebalancing and constituent weights shape ETF returns
What is the price of IMCV shares?

As of November 12, 2026, the stock is trading at USD 100.18 with a total of 34,637 shares traded. Over the past week, the price has changed by -0.54%, over one month by +5.63%, over three months by +3.54% and over the past year by +26.37%.

Current recommended Stop Loss: 97.70 (which is 2.5% or 2.2 ATR below the current price).

Is IMCV a buy, sell or hold?

Morningstar Mid-Cap Value has no consensus analysts rating.